Heparin

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
CardiacHematologic / Immuneneeds review

Heparin

ATI class: Anticoagulant / Unfractionated heparin

Action

  • ATI/source-folder candidate for Heparin; verify mechanism against the source table before validation.

Therapeutic use

  • Review under Coagulation Disorders medication safety.

Nursing assessment

  • Monitor aPTT or anti-Xa per protocol, platelets, bleeding, bruising, and infusion site.
  • Assess for HIT cues such as platelet drop or new thrombosis.
  • Verify weight-based dosing, pump settings, and independent double-check policy.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Bleeding
  • Heparin-induced thrombocytopenia
  • Thrombosis with HIT
  • Osteoporosis with long-term use
  • Hypersensitivity

Interactions

  • Antiplatelets
  • NSAIDs
  • Warfarin
  • Thrombolytics
  • Other anticoagulants

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Active major bleeding, history of HIT, severe thrombocytopenia, or uncontrolled bleeding risk.
  • Use caution after surgery, trauma, neuraxial procedures, or with high fall risk.

Client teaching

  • Report bleeding, black stools, severe headache, new bruising, or blood in urine.
  • Avoid unsafe OTC NSAIDs unless approved.
  • Use bleeding precautions and fall prevention.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Protamine sulfate is the classic heparin reversal concept.
  • Platelet drop plus new clot suggests HIT.
  • Pump or dose errors can rapidly become dangerous.

Medication classes

Anticoagulants

Source attribution

Google Drive source topic: Coagulation Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Anticoagulants

Reduces clot formation by interfering with the coagulation cascade.

ATI cuePrecaution
Active major bleeding, history of HIT, severe thrombocytopenia, or uncontrolled bleeding risk.

ATI medication precaution concept.

ATI cueClass
Anticoagulant

ATI medication class concept.

ATI cueInteraction
Antiplatelets

ATI medication interaction concept.

ATI cueNursing Assessment
Assess for HIT cues such as platelet drop or new thrombosis.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Heparin; verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueClient Teaching
Avoid unsafe OTC NSAIDs unless approved.

ATI medication client teaching concept.

ATI cueAdverse Effect
Bleeding

ATI medication adverse effect concept.

ATI cueAdverse Effect
Heparin-induced thrombocytopenia

ATI medication adverse effect concept.

ATI cueAdverse Effect
Hypersensitivity

ATI medication adverse effect concept.

ATI cueNursing Assessment
Monitor aPTT or anti-Xa per protocol, platelets, bleeding, bruising, and infusion site.

ATI medication nursing assessment concept.

ATI cueAntidote / Rescue
No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

ATI medication antidote / rescue concept.